Phylagen Receives Rigorous AOAC Validation for COVID-19 Indoor Test™


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Phylagen Receives Rigorous AOAC Validation for COVID-19 Indoor Test™
Phylagen recently awarded a Certificate of Validation from AOAC INTERNATIONAL for its COVID-19 Indoor Test™ that detects SARS-CoV-2 in any built environment.

Phylagen, the San Francisco-based biotech company focused on decoding the environmental microbiome for indoor safety was recently awarded a Certificate of Validation from AOAC INTERNATIONAL for its COVID-19 Indoor Test™ that detects SARS-CoV-2 in any built environment. Phylagen's test is one of the first to pass the rigorous independent evaluation required by the AOAC Research Institute's Performance Tested Methods™ Program and is currently the only certified SARS-CoV-2 indoor test kit solution available for anyone to purchase directly online.

Phylagen partnered with AOAC INTERNATIONAL at the beginning of the pandemic to be one of the first companies to undergo the rigorous test. During this initial validation process, the Phylagen COVID-19 Indoor Test™ and two other kits were evaluated for detection of the virus. To date, there has been no third-party certification available for indoor environmental testing.

"The rigor the AOAC brings makes it significant for Phylagen to be among the first cohort to receive AOAC's new Certificate of Validation for environmental testing of SARS-CoV-2," said Dr. Brad Taft, Ph.D., Chief Scientific Officer, Phylagen. "The emergence of the AOAC certification reinforces that indoor environmental testing for early detection of COVID-19 is becoming an evermore ubiquitous and essential tool for keeping populations in shared spaces safe."

The COVID-19 Indoor Test™ by Phylagen is a SARS-CoV-2 quantitative detection method that extracts the SARS-CoV-2 RNA from environmental swabs and detects it utilizing RT- PCR technology. Environmental surface swabs are collected by the customer and shipped back to Phylagen, Inc. for sample processing. Sample data are analyzed, and results are reported through a tracking portal.

Since the start of the pandemic, a wide range of businesses has turned to Phylagen to protect their workers by implementing regular indoor environmental testing. Manufacturing facilities shared workspaces, schools, and assisted living homes are just some of the businesses that have partnered with Phylagen to identify the presence of COVID-19.  The COVID-19 Indoor Test™ can be purchased online starting at $189 for five swabs. Custom solutions are also available for purchase. Once Phylagen receives the completed test swabs, results are delivered within 24 hours.  

About Phylagen

Phylagen is a San Francisco based biotech company committed to unlocking the global microbiome of built spaces. Phylagen's internationally recognized team of scientists turn dust into genomic data, providing crucial microbiome insights that impact indoor building health, supply chain traceability, and more.

Tags : #Phylagen #SANFRANCISCO #biotechcompany #AOACINTERNATIONAL #CertificateofValidation #Award #COVID-19IndoorTest #SARS-CoV-2 #ResearchInstitutesPerformanceTestedMethods #Covid-19Test #Covid-19Patients #DailyCovidUpdates

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
58 Students from SRM Medical College Selected for Union Government Research Programmes and Grants September 16, 2026
Handpickd Questions the Role of Science in Food with ‘Science-Less’ Newspaper CampaignSeptember 16, 2026
As Women’s Cancer Burden Rises, Integrated Care Emerges as The Next Frontier in Cancer TreatmentSeptember 16, 2026
Odia Superstar Babushaan Mohanty Inaugurates Manoj Das Library at Utkal Gaurav International SchoolSeptember 16, 2026
Yashoda Hospitals, Somajiguda Successfully Treats 10-Month-Old with Complex Heart Condition Through Staged ApproachSeptember 16, 2026
Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026
Can You Have PMOS With Regular Periods? What Women Often Get WrongSeptember 15, 2026
Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged ProstateSeptember 14, 2026
Dr. Reddy's Laboratories Launches Nationwide Educational Initiative to Strengthen India's Obesity Care WorkforceSeptember 14, 2026
IIM Bodh Gaya Hosts Convergence 3.0: The Next Frontier of Healthcare SectorSeptember 14, 2026